Used as a key chiral intermediate in the synthesis of antidiabetic drugs, particularly DPP-4 inhibitors like sitagliptin. Its stereochemistry enables high selectivity and potency in pharmaceutical formulations. The fluorinated aromatic structure enhances metabolic stability and binding affinity to the target enzyme. Commonly employed in asymmetric synthesis routes to ensure enantiomeric purity in active pharmaceutical ingredients.